China Resources Pharmaceutical Group Limited
CRPGF
$0.5414
$0.54140.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.51B | 3.66B | 4.55B | 4.58B | 4.55B |
| Total Receivables | 15.12B | 15.73B | 15.76B | 15.86B | 14.47B |
| Inventory | 5.08B | 5.28B | 5.09B | 5.12B | 4.50B |
| Prepaid Expenses | 558.45M | 581.11M | 1.00B | 1.01B | 676.50M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.20B | 1.25B | 790.38M | 795.46M | 995.24M |
| Total Current Assets | 25.46B | 26.49B | 27.19B | 27.37B | 25.18B |
|
|
|||||
| Total Current Assets | 25.46B | 26.49B | 27.19B | 27.37B | 25.18B |
| Net Property, Plant & Equipment | 3.55B | 3.69B | 3.41B | 3.43B | 3.53B |
| Long-term Investments | 3.06B | 3.19B | 2.95B | 2.97B | 3.03B |
| Goodwill | 3.06B | 3.19B | 2.95B | 2.97B | 3.03B |
| Total Other Intangibles | 951.84M | 990.46M | 1.08B | 1.09B | 921.75M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.45B | 1.50B | 1.07B | 1.07B | 1.17B |
| Total Assets | 35.31B | 36.75B | 36.65B | 36.89B | 34.80B |
|
|
|||||
| Total Accounts Payable | 8.05B | 8.38B | 8.08B | 8.13B | 7.68B |
| Total Accrued Expenses | 648.53M | 674.84M | 509.22M | 512.49M | 595.20M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.22B | 6.47B | 7.50B | 7.54B | 6.52B |
| Total Finance Division Other Current Liabilities | 3.20B | 3.33B | 3.73B | 3.75B | 4.14B |
| Total Other Current Liabilities | 3.20B | 3.33B | 3.73B | 3.75B | 4.14B |
| Total Current Liabilities | 18.11B | 18.85B | 19.81B | 19.94B | 18.93B |
|
|
|||||
| Total Current Liabilities | 18.11B | 18.85B | 19.81B | 19.94B | 18.93B |
| Long-Term Debt | 3.13B | 3.26B | 2.87B | 2.89B | 2.13B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 105.24M | 109.51M | 116.11M | 116.85M | 119.15M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 523.23M | 544.46M | 488.19M | 491.33M | 511.27M |
| Total Liabilities | 21.88B | 22.76B | 23.29B | 23.44B | 21.69B |
|
|
|||||
| Common Stock & APIC | 3.37B | 3.51B | 3.39B | 3.41B | 3.47B |
| Retained Earnings | 4.32B | 4.50B | 4.31B | 4.34B | 4.19B |
| Treasury Stock & Other | -1.09B | -1.13B | -1.05B | -1.05B | -1.18B |
| Total Common Equity | 6.61B | 6.88B | 6.66B | 6.70B | 6.48B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.61B | 6.88B | 6.66B | 6.70B | 6.48B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 6.83B | 7.11B | 6.71B | 6.75B | 6.63B |
| Total Equity | 13.44B | 13.98B | 13.36B | 13.45B | 13.11B |
|
|
|||||